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Abstract
There are limited data on the clinical signiﬁcance of positive central venous catheter (CVC) tip cultures associated with concomi-
tant negative blood cultures performed at the time of CVC removal. A retrospective cohort study of all patients who yielded iso-
lated positive CVC tip cultures was conducted in a tertiary-care hospital with 2200 beds during a 10-year period. All patients with
isolated positive CVC tip cultures were observed for the development of subsequent bacteraemia or fungaemia between 2 and
28 days after CVC removal. An isolated positive CVC tip culture was deﬁned as a case in which (i) a CVC tip culture yielded ‡15
colonies using a semiquantitative culture method and (ii) at least two sets of blood samples revealed no organism at, or close to,
the time of CVC removal (48 h before to 48 h after CVC removal). During the study period, 312 patients with isolated positive
CVC cultures were enrolled. Eight (2.6%; 95% CI 1.2–5.1) of the 312 patients yielding isolated bacterial or fungal CVC tip cultures
developed subsequent bloodstream infection (BSI) caused by the same species as that isolated from the tip culture (Staphylococcus
aureus, 1: Enterococcus spp.; 2: Pseudomonas aeruginosa; and 3: Candida spp.). Among 125 patients from whose CVC tips the above
four organisms were grown, seven (12.3%) of 57 patients who did not receive appropriate antibiotic therapy within 48 h after CVC
removal subsequently developed BSI, but only one (1.5%) of 68 patients who did receive appropriate therapy developed BSI (OR
0.11, p 0.02).
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Introduction
Semiquantitative culture of central venous catheter (CVC)
tips is useful for diagnosing CVC-related bloodstream infec-
tions (BSI) when it is carried out in conjunction with blood
culture [1–3]. Physicians occasionally encounter positive
CVC tip cultures associated with concomitant negative blood
cultures at, or close to, the time of CVC removal (i.e. iso-
lated positive CVC tip cultures). However, data on the clini-
cal signiﬁcance of the isolated positive CVC tip cultures are
limited [4]. Two recent studies showed that isolated Staphy-
lococcus aureus CVC tip cultures after CVC removal were
associated with a signiﬁcant risk of subsequent S. aureus bac-
teraemia [5,6]. In both studies, the incidence and clinical sig-
niﬁcance of isolated positive CVC tip cultures yielding
organisms other than S. aureus were not evaluated. There-
fore, we conducted the present study to evaluate the inci-
dence and clinical signiﬁcance of subsequent BSI in cases of
isolated bacterial and fungal CVC tip cultures in which two
or more sets of concomitant blood cultures were per-
formed.
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Materials and Methods
Study population
This study was performed at the Asan Medical Centre, a
2200-bed tertiary hospital, between January 1998 and
December 2007. All CVC tip culture results from patients
who were at least 16 years of age were retrospectively
retrieved from the computerized microbiological database.
Microbiological tests
During the study period, CVC tip cultures were carried out
using the semiquantitative role plate culture method described
by Maki et al. [2]. Antibiotic-impregnated catheters were not
used during the study period. Blood samples were cultured
using the BACTEC 9240 system (Becton Dickinson, Sparks,
MD, USA). Identiﬁcation and antimicrobial susceptibility test-
ing of the bacterial isolates were performed using the Micro-
Scan system (Dade Behring, West Sacramento, CA, USA), and
identiﬁcation and susceptibility testing of the fungal isolates
were performed using the RapID Yeast Plus system (Innovative
Diagnostic Systems, Atlanta, GA, USA) and ATB FUNGUS 3
(bioMe´rieux, Marcy I’Eltoile, France), respectively.
Deﬁnitions
An isolated positive CVC tip culture was deﬁned as a case in
which: (i) a CVC tip culture yielded ‡15 colonies using the
semiquantitative culture method of Maki et al. [2] and (ii) at
least two sets of blood samples drawn for culture (concomi-
tant blood cultures) revealed no microorganism at, or close
to, the time of CVC removal (48 h before to 48 h after
CVC removal). Subsequent BSI was deﬁned as a case of iso-
lation (from blood cultures performed between 2 and
28 days after CVC removal) of the same organism as, and of
an antibiogram identical to that of, the CVC tip isolate [6].
Exit-site infections and tunnel infections were deﬁned as
erythema, induration and/or tenderness within 2 cm of the
CVC exit site and along the subcutaneous tract of the CVC at
a distance >2 cm from the skin exit site, respectively [4]. The
empiric antibiotic treatment was considered appropriate if it
was given within 48 h after CVC removal, if it included at least
one antibiotic to which the CVC tip isolate was susceptible and
if this antibiotic was continued for a minimum of 3 days [5,6] .
Results
Baseline clinical characteristics
Over the 10-year period, 13 292 CVC tip cultures were
performed and there were 1961 cases in which CVC tip cul-
tures yielded ‡15 colonies (positive CVC tip cultures).
Among these, there were 847 cases of positive CVC tip cul-
tures in which at least two sets of blood cultures were per-
formed at, or close to, the time of CVC removal.
While 799 cases were evaluated, 48 were excluded for
the following reasons: incomplete medical records (n = 36)
and previous bacteraemia or fungaemia caused by the same
species as that isolated from a CVC tip culture 3 months
or less before CVC removal (n = 12). In 421 of the 799
cases, concomitant blood cultures yielded the same organ-
isms as those that were isolated from the CVC tip cul-
tures, whereas in 66 cases different organisms were
identiﬁed. Finally, 312 CVC tip cultures met the criteria of
isolated positive CVC tip culture. Two sets of concomitant
blood cultures were performed in 160 of these cases
(51%), and three or more in the remaining 152 cases
(49%). The baseline clinical characteristics of the 312 cases
are shown in Table 1.
TABLE 1. Demographic and clinical data for patients with
isolated positive central venous catheter tip cultures
Variable
Cases
without
subsequent
BSI (n = 304)
Cases with
subsequent
BSI (n = 8) pa
Age, mean years (95% CI) 57 (55–59) 62 (45–77) 0.52
Male sex (%) 206 (68) 6 (75) 1.00
Comorbid conditions (%)
Diabetes mellitus 70 (23) 3 (38) 0.40
Chronic liver disease 25 (8) 1 (13) 0.51
COPD 12 (4) 0 (0) 1.00
Use of mechanical ventilation 109 (36) 6 (75) 0.06
Solid organ malignancy 69 (23) 0 (0) 0.21
Haematological malignancy 19 (6) 0 (0) 1.00
Neutropeniab 11 (4) 0 (0) 1.00
Stay in ICU (%) 219 (72) 6 (75) 1.00
Duration of hospital stay after
CVC removal, median days (IQR)
24 (11–48) 24 (15–78) 0.20
Duration of catheter
use, median days (IQR)
10 (6–16) 11 (6–18) 0.82
Type of catheter (%)
Non-tunnelled 279 (92) 8 (100) 1.00
Tunnelled 25 (8) 0 (0)
Catheter insertion site (%)
Internal jugular vein 200 (66) 5 (63) 0.07
Subclavian vein 88 (29) 1 (12)
Femoral vein 16 (5) 2 (25)
Haemodialysis catheter (%) 29 (10) 2 (25) 0.18
Exit-site or tunnel infection (%) 15 (5) 1 (13) 0.35
Body temperature >38C (%) 211 (69) 5 (63) 0.71
Duration of fever before CVC
removal, median days (IQR)c
1 (0–3) 4 (1–9) 0.34
Receipt of parenteral nutrition (%) 183 (60) 6 (75) 0.49
Immunosuppressive therapy (%) 46 (15) 0 (0) 0.61
Systemic corticosteroid use (%) 89 (29) 1 (13) 0.45
Antibiotic treatment (%) 148 (49) 1 (13) 0.07
28-day mortality rate (%) 60 (20) 2 (25) 0.67
BSI, bloodstream infection; COPD, chronic obstructive pulmonary disease; ICU,
intensive care unit; CVC, central venous catheter; IQR, interquartile range.
ap Values were calculated using the Mann–Whitney U-test or Fisher’s exact test,
where appropriate.
bNeutropenia was deﬁned as an absolute neutrophil count of <1000 cells/lL.
cIncludes patients with a body temperature of >38C (n = 216).
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BSI subsequent to CVC removal
In eight (2.6%; 95% CI 1.2–5.1) of the 312 isolated cases of
positive CVC tip culture, subsequent BSI developed within
28 days of CVC removal. Subsequent S. aureus bacteraemia
developed in two (3.5%; 95% CI 0.3–12.4) of the 58
S. aureus cases, Enterococcus bacteraemia in one (9.1%; 95%
CI 0–39.9) of the 11 Enterococcus cases, Pseudomonas aeru-
ginosa bacteraemia in two (11.8%; 95% CI 2.0–35.6) of the
17 P. aeruginosa cases, and candidaemia in three of the 39
Candida cases (7.7%; 95% CI 1.9–21.0). The detailed data
are presented in Table 2. We also evaluated the association
between appropriate antibiotic therapy and incidence of
subsequent BSI in 125 cases in which CVC tip culture
yielded four organisms (S. aureus, Enterococcus spp., P. aeru-
ginosa and Candida spp.) associated with subsequent BSI
(Table 2). Seven (12.3%) of 57 patients who did not receive
appropriate antibiotic therapy within 48 h after CVC
removal developed subsequent BSI, but only one (1.5%) of
68 patients who received appropriate antibiotic therapy
developed subsequent BSI (OR 0.11; p 0.02). None of the
three patients who developed subsequent candidaemia was
given appropriate antifungal therapy within 48 h of CVC
removal and all died of subsequent fungal septic shock.
Although only one of the ﬁve patients who developed sub-
sequent bacteraemia (the isolated case of S. aureus CVC tip
culture) was given an appropriate antibiotic (to which the
isolate was susceptible within 48 h after CVC removal),
none died of subsequent bacteraemia (Table 3). In addition,
we evaluated the association between appropriate antibiotic
treatment and the 28-day mortality rate. Thirty-one (19%)
of 163 patients who did not receive appropriate antibiotic
therapy died within 28 days after CVC removal and 31
(21%) of 149 patients who received appropriate antibiotic
therapy died (p 0.77). We also evaluated this association in
58 cases in which CVC tip cultures yielded S. aureus. Four
(21%) of 19 patients who did not receive appropriate anti-
biotic therapy died within 28 days after CVC removal and
11 (28%) of 39 patients who received appropriate antibiotic
therapy died (p 0.75).
Discussion
There are limited data in the literature to guide clinicians
regarding the use of antimicrobial therapy for patients with
isolated positive CVC tip cultures. The current recommen-
dation is that a febrile patient with valvular heart disease or
a patient with neutropenia (absolute neutrophil count
<1000 cells/mL), whose catheter tip culture shows signiﬁcant
growth of S. aureus or Candida albicans, should be observed
closely for signs of infection or receive a short course (5–
7 days) of antibiotics [4]. The main ﬁnding of the present
study is that BSI is rare subsequent to the removal of colo-
nized CVCs in patients with negative concomitant blood cul-
tures. However, there was a trend toward a more frequent
occurrence of subsequent candidaemia (7.7% [3/39]; 95% CI
TABLE 2. Development of bloodstream infections subsequent to central venous catheter removal in patients with isolated
positive central venous catheter cultures
Organisms
Positive
CVC tip
culturesa
Subsequent
BSI/isolated
culture-positive
CVC tips (%)
Subsequent BSI/isolated
culture-positive CVC tips (%)
pb
Appropriate
antibiotic
therapy
Inappropriate
antibiotic
therapy
Staphylococcus aureus 472 2/58 (3.5) 1/39 (2.6) 1/19 (5.3) 1.00
Methicillin susceptible 82 0/10 (0) 0/7 (0) 0/3 (0) N/A
Methicillin resistant 390 2/48 (4.2) 1/32 (3.1) 0/16 (6.3) N/A
CoNS 422 0/91 (0) 0/44 (0) 0/47 (0) N/A
Methicillin susceptible 40 0/9 (0) 0/8 (0) 0/1 (0) N/A
Methicillin resistant 382 0/82 (0) 0/36 (0) 0/46 (0) N/A
Enterococcus spp. 52 1/11 (9.1) 0/7 (0) 1/4 (25.0) 0.36
Gram-negative bacilli 292 2/75 (2.7) 0/30 (0) 2/45 (4.4) 0.51
Acinetobacter baumannii 105 0/35 (0) 0/8 (0) 0/27 (0) N/A
Pseudomonas aeruginosa 53 2/17 (11.8) 0/9 (0) 2/8 (25.0) 0.21
Enterobacter spp. 33 0/12 (0) 0/6 (0) 0/6 (0) N/A
Escherichia coli and Klebsiella spp. 48 0/8 (0) 0/5 (0) 0/3 (0) N/A
Others 53 0/3 (0) 0/2 (0) 0/1 (0) N/A
Candida spp. 232 3/39 (7.7) 0/13 (0) 3/26 (11.5) 0.54
Candida albicans 115 2/22 (9.1) 0/6 (0) 2/16 (12.5) N/A
Non-albicans Candida spp. 117 1/17 (5.9) 0/7 (0) 1/10 (10.0) 1.00
Polymicrobial 491 0/38 (0) 0/16 (0) 0/22 (0) 1.00
Total 1961 8/312 (2.6) 1/149 (0.7) 7/163 (4.3) 0.07
CVC, central venous catheter; BSI, bloodstream infection; CoNS, coagulase-negative staphylococci.
aRegardless of whether concomitant blood cultures were drawn or not.
bp Values calculated using Fisher’s exact test.
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1.9–21.0) than of subsequent bacteraemia (1.8% [5/273]; 95%
CI 0.7–4.3) (see Table 2), although it was not statistically sig-
niﬁcant (p 0.07).
Unfortunately, in our study, each of the three patients
who developed candidaemia, none of whom was given timely
appropriate antifungal therapy, died of septic shock. Our data
thus suggest that systemic antibiotics might be beneﬁcial
for patients whose catheter tip culture shows signiﬁcant
growth of Candida spp. regardless of a neutropenic status or
underlying valvular heart disease. In contrast to the situation
with Candida spp., no subsequent bacteraemia developed in
the cases involving isolated coagulase-negative staphylococci
(CoNS), or Gram-negative bacilli other than P. aeruginosa. In
previous studies, CVC tip cultures of S. aureus were fre-
quently associated with positive concomitant blood cultures
[5,7,8]. In the present study, 193 (70.2%) of 275 S. aureus
CVC tip cultures were accompanied by concomitant positive
blood cultures. This ﬁnding is consistent with the previous
reports [7,8]. Furthermore, in two previous studies, 12%
(12/77) and 14% (14/99) of patients with isolated CVC tip
cultures yielding S. aureus developed subsequent S. aureus
bacteraemia, respectively [5,6]. Interestingly, in our study
only two (3.4%) of the 58 patients with isolated CVC tip cul-
tures yielding S. aureus developed subsequent S. aureus bac-
teraemia. Although the reason for this difference is unclear,
statistical variability or differences among patient groups are
possible explanations. In addition, it is probably at least partly
accounted for by differences in the number of patients for
whom concomitant blood cultures were performed. In one
study, concomitant blood cultures were performed in only
44 (57.1%) of the 77 cases involving isolated tip cultures
yielding S. aureus [5]. In the other study [6], it was unclear for
how many patients concomitant blood cultures from periph-
eral veins were performed at the time of CVC removal.
Therefore, the discrepancy with our study may be due to fail-
ure to demonstrate S. aureus bacteraemia at that time. Also, a
small proportion of patients (50/99, 51%) received appropri-
ate antibiotic therapy in the study by Ekkelenkamp et al. [6]
compared with that in our study (39/58, 67%).
In the study by Ekkelenkamp et al. [6], two (4.0%, 95% CI
0–9.4) of the 50 patients who received appropriate antibiotic
therapy developed subsequent S. aureus bacteraemia. In our
study, one (2.6%, 95% CI 0–9.4) of the 38 patients who
received appropriate antibiotic therapy developed subse-
quent S. aureus bacteraemia (Table 2).
In addition, our study showed that inappropriate antibiotic
therapy was associated with development of subsequent BSI.
This ﬁnding is consistent with previous reports [5,6]. How-
ever, this result was not conﬁrmed by multivariate analysis
because of the small number of subsequent bacteraemic or
fungaemic events. We also failed to ﬁnd a signiﬁcant associa-
tion between appropriate antibiotic therapy and subsequent
BSI due to different organisms (Table 2). At the time of the
writing of this manuscript, Perez-Parra et al. [9] reported
that, in non-neutropenic, critically ill patients with isolated
tip cultures yielding Candida, antifungal therapy did not have
a signiﬁcant inﬂuence on clinical outcome. They also showed
that only one (1.7%, 95% CI 0–5.1) of the 58 patients with
isolated tip cultures yielding Candida developed subsequent
candidaemia [9]. However, they excluded ﬁve patients with
positive blood cultures within 7 days after catheter removal.
Thus, they deﬁned subsequent candidaemia as isolation of
Candida from peripheral blood cultures performed 7 days
after CVC removal, whereas we deﬁned subsequent bactera-
TABLE 3. Eight patients with bloodstream infections subsequent to the removal of a colonized central venous catheter
Patient Sex
Age,
years Organism
Underlying
conditions
Onset of
BSI after
CVC
removal,
days
Appropriate
antibiotics
ANC <
1000 Echo
Focus of
subsequent BSI
Status (cause
of death or
duration of
follow-up, months)
1 M 56 Staphylococcus
aureus
ICH 9 No No TTE (no VHD) Central vein
septic
thrombophlebitis
Alive (24)
2 M 72 S. aureus Pneumonia ARDS 3 Yes No TEE (no VHD) Not known Deceased at day 27 after
CVC removal (ARDS)
3 F 47 Pseudomonas
aeruginosa
CAD (3VD) 24 No No TTE (no VHD) Not known Deceased at day 33 after
CVC removal (MOF)
4 M 40 P. aeruginosa ESLD 16 No No TTE (no VHD) Not known Alive (28)
5 M 75 E. faecium ALF 4 No No Not done Not known Alive (44)
6 M 94 Candida albicans Necrotizing
pancreatitis
13 No No Not done Not known Deceased at day 13 after
CVC removal (septic shock)
7 M 56 C. albicans CAD (3VD) 9 No No TTE (no VHD) Not known Deceased at day 15 after
CVC removal (septic shock)
8 M 72 Non-albicans
Candida
Acute mesenteric
ischaemia
11 No No Not done Not known Deceased at day 13 after
CVC removal (septic shock)
BSI, bloodstream infection; CVC, central venous catheter; ANC, absolute neutrophil count; Echo, Echocardiography; ICH, intracranial haemorrhage; TTE, transthoracic
echocardiography; VHD, valvular heart disease; ARDS, acute respiratory distress syndrome; TEE, transoesophageal echocardiography; CAD, coronary artery disease; 3VD,
three vessel disease; MOF, multiorgan failure; ESLD, end-stage liver disease; ALF, acute liver failure.
CMI Park et al. Isolated positive central venous catheter tip cultures 745
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 742–746
emia as isolation from blood cultures (performed 2 days
after CVC removal) of the same organism as that isolated
from the CVC tips.
Our study has some limitations. The species involved in
many of the CVC tip cultures yielding CoNS and non-albicans
Candida spp. were not identiﬁed. However, we believe that
this factor did not substantially affect the rate of develop-
ment of subsequent BSI, since there were no subsequent
cases of bacteraemia due to CoNS and only one subsequent
case of non-albicans candidaemia. Because blood and CVC
tip isolates were not available for typing, we could not con-
ﬁrm their possible relatedness. We also could not evaluate
some potential risk factors such as those linked to the inser-
tion of new CVCs after removal of colonized CVCs.
Our study was also limited by its retrospective design; it
may be argued that there have been some sources of BSI other
than the CVC tips. Also, the sample size and heterogeneity of
our patient group limit the power of statistical analysis.
In conclusion, we have shown that the overall incidence of
BSI was low after removal of colonized CVCs in patients
with isolated positive CVC tip cultures. It was higher in cases
involving Candida spp., regardless of neutropenia or valvular
heart disease. Our data suggest that systemic antibiotic treat-
ment be given to those patients whose CVC tip cultures
show signiﬁcant growth of Candida spp.
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